DOCSLIB.ORG

Tsukushi Functions As a Wnt Signaling Inhibitor by Competing with Wnt2b for Binding to Transmembrane Protein Frizzled4

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tsukushi Functions As a Wnt Signaling Inhibitor by Competing with Wnt2b for Binding to Transmembrane Protein Frizzled4 Tsukushi functions as a Wnt signaling inhibitor by competing with Wnt2b for binding to transmembrane protein Frizzled4 Kunimasa Ohtaa,b,1,2, Ayako Itoa,c,1, Sei Kuriyamaa,d,3, Giuseppe Lupoe,f, Mitsuko Kosakag,4, Shin-ichi Ohnumah, Shinichi Nakagawai, and Hideaki Tanakaa,c,d aDepartment of Developmental Neurobiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan; bPrecursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama 332-0012, Japan; cGlobal Center of Excellence, Kumamoto University, Kumamoto 860-8556, Japan; d21st Century Center of Excellence, Kumamoto University, Kumamoto 860-8556, Japan; eDepartment of Biology and Biotechnology “C. Darwin,” University of Rome “La Sapienza,” 00185 Rome, Italy; fIstituto Pasteur–Fondazione Cenci Bolognetti, 00185, Rome, Italy; gRIKEN Center for Developmental Biology, Kobe 650-0047, Japan; hInstitute of Ophthalmology, University College London, London EC1V 9EL, United Kingdom; and IRIKEN Advanced Science Institute, Nakagawa RNA Biology Laboratory, Saitama 351-0198, Japan Edited* by Lynn T. Landmesser, Case Western Reserve University, Cleveland, OH, and approved July 8, 2011 (received for review January 11, 2011) The Wnt signaling pathway is essential for the development of We previously described the isolation of Tsukushi (TSK) protein diverse tissues during embryogenesis. Signal transduction is acti- isoforms (13), soluble molecules belonging to the small leucine- vated by the binding of Wnt proteins to the type I receptor low- rich proteoglycan (SLRP) family (14), and showed that they work density lipoprotein receptor–related protein 5/6 and the seven-pass as extracellular modulators of pivotal signaling cascades during transmembrane protein Frizzled (Fzd), which contains a Wnt- early embryonic development in chicks and frogs (13, 15–17). We binding site in the form of a cysteine-rich domain. Known extracel- also observed that TSK rescues Xenopus embryos from the lular antagonists of the Wnt signaling pathway can be subdivided hyperdorsalized effects induced by Wnts (Fig. S1). In this study, we into two broad classes depending on whether they bind primarily to show that TSK functions as a novel Wnt signaling inhibitor by Wntortolow-densitylipoproteinreceptor–related protein 5/6. We competing with Wnt2b for binding to Fzd4. Our biochemical show that the secreted protein Tsukushi (TSK) functions as a Wnt analysis demonstrates direct binding between TSK and Fzd4 with −10 signaling inhibitor by binding directly to the cysteine-rich domain of an affinity of 2.3 × 10 M. Using overexpression assays in chicken − Fzd4 with an affinity of 2.3 × 10 10 M and competing with Wnt2b. In embryonic retinal cells, we found that TSK inhibits Wnt2b activity the developing chick eye, TSK is expressed in the ciliary/iris epithe- both in vitro and in vivo and represses Wnt2b-dependent induction lium, whereas Wnt2b is expressed in the adjacent anterior rim of the of peripheral eye character. Conversely, TSK inactivation results in optic vesicle, where it controls the differentiation of peripheral eye expansion of the CB in mice. Consequently, TSK is an important structures, such as the ciliary body and iris. TSK overexpression ef- component of the molecular pathways controlling retinal and pe- fectively antagonizes Wnt2b signaling in chicken embryonic retinal ripheral eye development. fi cells both in vivo and in vitro and represses Wnt-dependent speci - Results cation of peripheral eye fates. Conversely, targeted inactivation of the TSK gene in mice causes expansion of the ciliary body and up- Expression of TSK at the Peripheral Chick Retina. There is substantial regulation of Wnt2b and Fzd4 expression in the developing periph- evidence that the Wnt signaling pathway controls the development eral eye. Thus, we uncover a crucial role for TSK as a Wnt signaling of peripheral eye structures in several animal models (8, 12, 18– inhibitor that regulates peripheral eye formation. 20). TSK is expressed in the peripheral region of the developing chick eye at E6 (Fig. S2 A and B). As shown in Fig. S2C,Wnt2b eye development | signaling modulator | small leucine-rich proteoglycan expression is localized to the anteriormost tip of the optic cup, whereas chick TSKB (C-TSKB) (15) is expressed in the adjacent ciliary/iris epithelium (Fig. S2B). Comparing C-TSKB expression nt signaling is involved in multiple developmental events with the expression pattern of collagen IX (Fig. S2F), a marker of during embryogenesis and it has also been implicated in W the neighboring ciliary/iris epithelium (8, 21), shows that C-TSKB adult tissue homeostasis (1, 2). Wnt proteins act on target cells by binding to the Frizzled (Fzd)/low-density lipoprotein receptor– expression does not extend into the ciliary epithelium region. Other Wnt ligands, such as Wnt3a and Wnt6, are not transcribed related protein (LRP) complex at the cell surface, which trans- G duces Wnt signals into the target cells (3, 4). Extracellular antag- in the developing peripheral eye (Fig. S2 ). Fzd1, 3, and 4 are onists of the Wnt signaling pathway can be subdivided into two expressed in both the ciliary and the iris epithelia, whereas Fzd5 is D E G broad classes: the secreted Fzd-related protein class and the not expressed in either of these areas (Fig. S2 , ,and ). These Dikkopf class (5). The members of the secreted Fzd-related pro- expression patterns suggest that Wnt2b and C-TSKB could func- tein class bind directly to Wnts and alter their ability to bind to the Wnt receptor complex, whereas members of the Dikkopf family inhibit Wnt signaling by binding to the LRP5/LRP6 component of Author contributions: K.O., A.I., G.L., S.-i.O., and H.T. designed research; K.O., A.I., and the Wnt receptor complex. A Wnt inhibitor that specifically binds S.K. performed research; M.K. and S.N. contributed new reagents/analytic tools; K.O., A.I., to the Fzd receptor has not yet been identified, however. and S.K. analyzed data; and K.O. and G.L. wrote the paper. The peripheral rim of the optic cup is a unique region of the The authors declare no conflict of interest. developing eye that forms two of the peripheral support tissues, *This Direct Submission article had a prearranged editor. the ciliary body (CB) and the iris (6). These tissues are composed 1K.O. and A.I. contributed equally to this work. of a nonpigmented inner layer, which is continuous with the retina, 2To whom correspondence should be addressed. E-mail: [email protected]. and a pigmented outer layer, which is continuous with the retinal jp. pigmented epithelium (7). Cho and Cepko (8) performed gain-of- 3Present address: Department of Molecular Medicine and Biochemistry, Akita University function analyses in vivo and found that retinal cells exposed to Graduate School of Medicine and Faculty of Medicine, Akita 010-8543, Japan. high levels of Wnt signaling are induced to acquire CB and iris cell 4Present address: Okayama University Graduate School of Medicine, Dentistry and Phar- fates. Thus, Wnt signaling is involved in the differentiation of maceutical Sciences, Okayama 700-8558, Japan. peripheral eye structures, but the molecular interactions involved This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. are not yet clearly understood (8–12). 1073/pnas.1100513108/-/DCSupplemental. 14962e14967 | PNAS | September 6, 2011 | vol. 108 | no. 36 www.pnas.org/cgi/doi/10.1073/pnas.1100513108 Downloaded by guest on September 25, 2021 tionally interact with each other and regulate Fzd-dependent sig- Wnt2b in the chick optic vesicle and observed the effects on the naling in the peripheral eye. proliferation of retinal explants and the expression of the CB marker collagen IX, both of which are stimulated by Wnt2b (22). TSK Inhibits Wnt2b Activity in Vitro. To address whether TSK We first electroporated the optic vesicles of E1.5 chicken embryos functions as a Wnt inhibitor, we co-overexpressed C-TSKB with with a Wnt2b-expressing provirus as described previously (22). We then dissected explants of the electroporated retinal tissues (250 × 250 μm2 surface area) from the central region of E5.5 retinas and cultured them in vitro for 8 d (Fig. 1A). Confirming the results of A 2days 4days layer formation control Wnt2b Wnt2b + C-TSKB B DF GFP C EG BMP7 HKN GFP ILO collagen IX JMP DAPI NEUROSCIENCE Q m) μ 180 * * 150 * 120 90 60 30 Thickness of retinal layer ( 0 Wnt2b C-TSKB control-GFP Wnt2b + C-TSKB Wnt2b + C-TSKB-LRR6Wnt2b + C-TSKB-LRR4Wnt2b + C-TSKB-LRR3Wnt2b + C-TSKB-LRR2 Fig. 1. TSK inhibits Wnt activity in vitro. (A) Schematic of the experimental Fig. 2. TSK inhibits Wnt activity in vivo. (A) Schematic of the experimental procedure. (B–G) BrdU incorporation was increased in the explants expressing procedure. (B–P) Histological sections of central retinal regions from chicken Wnt2b. (B and C) DAPI. (D and E)GFP.(F and G) BrdU. (Scale bar: 100 μm.) (H– embryos electroporated with the indicated DNA constructs plus RCAS:GFP at J) Retinal explants of control (H), Wnt2b- (I), and Wnt2b+C-TSKB–expressing E1.5 and incubated for 6 d in vivo. (B, D, F, H, K,andN) GFP expression. (C, E, chick retinas (J), which were dissected out at E5.5 and cultured for 8 d in vitro and G) Expression of BMP7 detected by in situ hybridization. (I, L, and O)Ex- after electroporation at E1.5. The arrow in H points to an explant immediately pression of collagen IX detected by immunohistochemistry. White arrowheads after dissection. RCAS:GFP was cotransfected to visualize electroporated cells. indicate the immunoreactivity of anti-collagen IX antibody on the choroid. (K–P) Expression of collagen IX in the explants expressing Wnt2b. (K, M,and (J, M,andP) DAPI. Note that the thinning and folding of the retinal epithelium O) DAPI.
Load more

Recommended publications
  • Genetic Variants in WNT2B and BTRC Predict Melanoma Survival
    ACCEPTED MANUSCRIPT Genetic Variants in WNT2B and BTRC Predict Melanoma Survival Qiong Shi1, 2, 3, 9, Hongliang Liu2, 3, 9, Peng Han2, 3, 4, 9, Chunying Li1, Yanru Wang2, 3, Wenting Wu5, Dakai Zhu6, Christopher I. Amos6, Shenying Fang7, Jeffrey E. Lee7, Jiali Han5, 8* and Qingyi Wei2, 3* 1Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China; 2Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, 3Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA, 4Department of Otorhinolaryngology Head and Neck Surgery, First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710061, China; 5Department of Epidemiology, Fairbanks School of Public Health, Indiana University Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis,MANUSCRIPT IN 46202, USA 6Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA; 7Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. 8Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA 9These authors contributed equally to this work. ACCEPTED *Correspondence: Qingyi Wei, M.D., Ph.D., Duke Cancer Institute, Duke University Medical Center and Department of Medicine, Duke School of Medicine, 905 S LaSalle Street, Durham, NC 27710, USA, Tel.: (919) 660-0562, E-mail: [email protected] and Jiali Han, M.D., Ph.D., 1 _________________________________________________________________________________ This is the author's manuscript of the article published in final edited form as: Shi, Q., Liu, H., Han, P., Li, C., Wang, Y., Wu, W., … Wei, Q.
    [Show full text]
  • The Wnt Signaling Pathway in Tumorigenesis, Pharmacological
    Wang et al. Biomarker Research (2021) 9:68 https://doi.org/10.1186/s40364-021-00323-7 REVIEW Open Access The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy Zhuo Wang1,2†, Tingting Zhao1,2†, Shihui Zhang3, Junkai Wang1, Yunyun Chen1,2, Hongzhou Zhao1,2, Yaxin Yang4, Songlin Shi2, Qiang Chen5 and Kuancan Liu1,2* Abstract Wnt signaling was initially recognized to be vital for tissue development and homeostasis maintenance. Further studies revealed that this pathway is also important for tumorigenesis and progression. Abnormal expression of signaling components through gene mutation or epigenetic regulation is closely associated with tumor progression and poor prognosis in several tissues. Additionally, Wnt signaling also influences the tumor microenvironment and immune response. Some strategies and drugs have been proposed to target this pathway, such as blocking receptors/ligands, targeting intracellular molecules, beta-catenin/TCF4 complex and its downstream target genes, or tumor microenvironment and immune response. Here we discuss the roles of these components in Wnt signaling pathway in tumorigenesis and cancer progression, the underlying mechanisms that is responsible for the activation of Wnt signaling, and a series of drugs targeting the Wnt pathway provide multiple therapeutic values. Although some of these drugs exhibit exciting anti-cancer effect, clinical trials and systematic evaluation should be strictly performed along with multiple-omics technology. Keywords: Wnt signaling, beta-catenin, Epigenetic modification, Tumor microenvironment, Drug development Background polyposis coli (APC), glycogen synthase kinase-3β (GSK- The Wnt signaling cascade is critical for tissue morpho- 3β), Axin, casein kinase 1(CK1). Degradation of beta- genesis, homeostasis, and regeneration.
    [Show full text]
  • WNT4 and WNT3A Activate Cell Autonomous Wnt Signaling Independent of Secretion
    bioRxiv preprint doi: https://doi.org/10.1101/333906; this version posted September 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Running Title: Secretion-independent Wnt signaling Research article WNT4 and WNT3A activate cell autonomous Wnt signaling independent of secretion Deviyani M. Rao1, Rebecca L. Ferguson1, Tomomi M. Yamamoto2, Benjamin G. Bitler2, Matthew J. Sikora1 Affiliation: 1Dept. of Pathology, 2Dept. of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus Corresponding author: Matthew J. Sikora, PhD.; Mail Stop 8104, Research Complex 1 South, Room 5117, 12801 E. 17th Ave.; Aurora, CO 80045. Tel: (303)724-4301; Fax: (303)724-3712; email: [email protected]. Twitter: @mjsikora Funding This work was supported by R00 CA193734 (MJS) and R00 CA194318 (BGB) from the National Institutes of Health, and by a grant from the Cancer League of Colorado, Inc (MJS). Authors' contributions DMR and MJS conceived of the project and experiments. DMR, RLF, and MJS designed and performed experiments. RLF, DMR, and TMY developed models for the project. DMR, RLF, BGB, and MJS contributed to data analysis and interpretation. DMR wrote the draft manuscript; all authors read and revised the manuscript, and have read and approved of this version of the manuscript. bioRxiv preprint doi: https://doi.org/10.1101/333906; this version posted September 14, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
    International Journal of Molecular Sciences Review Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response Casey D. Stefanski 1,2 and Jenifer R. Prosperi 1,2,3,* 1 Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46617, USA; [email protected] 2 Mike and Josie Harper Cancer Research Institute, South Bend, IN 46617, USA 3 Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-South Bend, South Bend, IN 46617, USA * Correspondence: [email protected]; Tel.: +1-574-631-4002 Received: 30 September 2020; Accepted: 20 October 2020; Published: 22 October 2020 Abstract: Resistance to chemotherapy occurs through mechanisms within the epithelial tumor cells or through interactions with components of the tumor microenvironment (TME). Chemoresistance and the development of recurrent tumors are two of the leading factors of cancer-related deaths. The Adenomatous Polyposis Coli (APC) tumor suppressor is lost in many different cancers, including colorectal, breast, and prostate cancer, and its loss correlates with a decreased overall survival in cancer patients. While APC is commonly known for its role as a negative regulator of the WNT pathway, APC has numerous binding partners and functional roles. Through APC’s interactions with DNA repair proteins, DNA replication proteins, tubulin, and other components, recent evidence has shown that APC regulates the chemotherapy response in cancer cells. In this review article, we provide an overview of some of the cellular processes in which APC participates and how they impact chemoresistance through both epithelial- and TME-derived mechanisms. Keywords: adenomatous polyposis coli; chemoresistance; WNT signaling 1.
    [Show full text]
  • Evolutionarily Conserved Tbx5–Wnt2/2B Pathway Orchestrates Cardiopulmonary Development
    Evolutionarily conserved Tbx5–Wnt2/2b pathway orchestrates cardiopulmonary development Jeffrey D. Steimlea,b,c, Scott A. Rankind,e,f,g, Christopher E. Slagleh,i,j,k, Jenna Bekenya,b,c, Ariel B. Rydeena,b,c, Sunny Sun-Kin Chanl,m, Junghun Kweona,b,c, Xinan H. Yanga,b,c, Kohta Ikegamia,b,c, Rangarajan D. Nadadura,b,c, Megan Rowtona,b,c, Andrew D. Hoffmanna,b,c, Sonja Lazarevica,b,c, William Thomasn,o, Erin A. T. Boyle Andersonp, Marko E. Horbn,o, Luis Luna-Zuritaq,r, Robert K. Hom, Michael Kybal,m, Bjarke Jensens, Aaron M. Zornd,e,f,g, Frank L. Conlonh,i,j,k, and Ivan P. Moskowitza,b,c,1 aDepartment of Pediatrics, University of Chicago, Chicago, IL 60637; bDepartment of Pathology, University of Chicago, Chicago, IL 60637; cDepartment of Human Genetics, University of Chicago, Chicago, IL 60637; dCenter for Stem Cell and Organoid Medicine, Cincinnati Children’s Research Foundation, Cincinnati, OH 45229; eDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; fDivision of Developmental Biology, Perinatal Institute, Cincinnati Children’s Research Foundation, Cincinnati Children’s Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45229; gDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45229; hDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; iDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; jIntegrative Program for Biological and Genome Sciences, University of North
    [Show full text]
  • Deregulated Wnt/Β-Catenin Program in High-Risk Neuroblastomas Without
    Oncogene (2008) 27, 1478–1488 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc ONCOGENOMICS Deregulated Wnt/b-catenin program in high-risk neuroblastomas without MYCN amplification X Liu1, P Mazanek1, V Dam1, Q Wang1, H Zhao2, R Guo2, J Jagannathan1, A Cnaan2, JM Maris1,3 and MD Hogarty1,3 1Division of Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA; 2Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA and 3Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA Neuroblastoma (NB) is a frequently lethal tumor of Introduction childhood. MYCN amplification accounts for the aggres- sive phenotype in a subset while the majority have no Neuroblastoma (NB) is a childhood embryonal malig- consistently identified molecular aberration but frequently nancy arising in the peripheral sympathetic nervous express MYC at high levels. We hypothesized that acti- system. Half of all children with NB present with features vated Wnt/b-catenin (CTNNB1) signaling might account that define their tumorsashigh riskwith poor overall for this as MYC is a b-catenin transcriptional target and survival despite intensive therapy (Matthay et al., 1999). multiple embryonal and neural crest malignancies have A subset of these tumors are characterized by high-level oncogenic alterations in this pathway. NB cell lines without genomic amplification of the MYCN proto-oncogene MYCN amplification express higher levels of MYC and (Matthay et al., 1999) but the remainder have no b-catenin (with aberrant nuclear localization) than MYCN- consistently identified aberration to account for their amplified cell lines.
    [Show full text]
  • Towards an Integrated View of Wnt Signaling in Development Renée Van Amerongen and Roel Nusse*
    HYPOTHESIS 3205 Development 136, 3205-3214 (2009) doi:10.1242/dev.033910 Towards an integrated view of Wnt signaling in development Renée van Amerongen and Roel Nusse* Wnt signaling is crucial for embryonic development in all animal Notably, components at virtually every level of the Wnt signal species studied to date. The interaction between Wnt proteins transduction cascade have been shown to affect both β-catenin- and cell surface receptors can result in a variety of intracellular dependent and -independent responses, depending on the cellular responses. A key remaining question is how these specific context. As we discuss below, this holds true for the Wnt proteins responses take shape in the context of a complex, multicellular themselves, as well as for their receptors and some intracellular organism. Recent studies suggest that we have to revise some of messengers. Rather than concluding that these proteins are shared our most basic ideas about Wnt signal transduction. Rather than between pathways, we instead propose that it is the total net thinking about Wnt signaling in terms of distinct, linear, cellular balance of signals that ultimately determines the response of the signaling pathways, we propose a novel view that considers the receiving cell. In the context of an intact and developing integration of multiple, often simultaneous, inputs at the level organism, cells receive multiple, dynamic, often simultaneous and of both Wnt-receptor binding and the downstream, sometimes even conflicting inputs, all of which are integrated to intracellular response. elicit the appropriate cell behavior in response. As such, the different signaling pathways might thus be more intimately Introduction intertwined than previously envisioned.
    [Show full text]
  • Hippocampus Formation: an Intriguing Collaboration Henk Roelink
    bb10g06.qxd 04/03/2000 01:10 Page R279 Dispatch R279 Hippocampus formation: An intriguing collaboration Henk Roelink Recent genetic studies have shown that the signalling temporal lobes are formed. In an adult rodent, the hip- factor Wnt3a is required for formation of the pocampus is consequently still found close to the dorsal hippocampus; the developmental consequences of Wnt midline where it is initially formed (Figure 1). signalling in the hippocampus are mediated by multiple HMG-box transcription factors, with LEF-1 being It is clear that Wnt family members are required for the required just for formation of the dentate gyrus. development of many embryonic structures, functions mediated by their effects on fundamental processes such Address: Department of Biological Structure and Center for Developmental Biology, University of Washington, Box 357420, as cell proliferation, differentiation, survival or mainte- Seattle, Washington 98117-7420, USA. nance. Obtaining a clear picture of how each Wnt acts is E-mail: [email protected] complicated by the relatively large size of the family, which has at least 18 members in amniotes [3]. Analyses of Current Biology 2000, 10:R279–R281 mice lacking one or several Wnt genes have revealed some 0960-9822/00/$ – see front matter remarkable phenotypes, often characterized by failure of © 2000 Elsevier Science Ltd. All rights reserved. induction of very specific anatomical structures. Wnt3A is no exception, and although several papers have been pub- Inductive interactions are fundamental to the formation of lished already on the more obvious defects of Wnt3a all brain structures. and signalling by molecules of the knockout mice, a recent paper from McMahon and col- Wingless/Wnt family is known to play a role in many of leagues [1] has reported a very interesting defect in the them.
    [Show full text]
  • A Membrane-Associated Β-Catenin/Oct4 Complex Correlates
    DEVELOPMENT AND STEM CELLS RESEARCH ARTICLE 1171 Development 140, 1171-1183 (2013) doi:10.1242/dev.085654 © 2013. Published by The Company of Biologists Ltd A membrane-associated β-catenin/Oct4 complex correlates with ground-state pluripotency in mouse embryonic stem cells Fernando Faunes1,*, Penelope Hayward1,*, Silvia Muñoz Descalzo1, Sujash S. Chatterjee2, Tina Balayo1, Jamie Trott1, Andrew Christoforou1,3, Anna Ferrer-Vaquer4, Anna-Katerina Hadjantonakis4, Ramanuj Dasgupta2 and Alfonso Martinez Arias1,‡ SUMMARY The maintenance of pluripotency in mouse embryonic stem cells (mESCs) relies on the activity of a transcriptional network that is fuelled by the activity of three transcription factors (Nanog, Oct4 and Sox2) and balanced by the repressive activity of Tcf3. Extracellular signals modulate the activity of the network and regulate the differentiation capacity of the cells. Wnt/β-catenin signaling has emerged as a significant potentiator of pluripotency: increases in the levels of β-catenin regulate the activity of Oct4 and Nanog, and enhance pluripotency. A recent report shows that β-catenin achieves some of these effects by modulating the activity of Tcf3, and that this effect does not require its transcriptional activation domain. Here, we show that during self-renewal there is negligible transcriptional activity of β-catenin and that this is due to its tight association with membranes, where we find it in a complex with Oct4 and E-cadherin. Differentiation triggers a burst of Wnt/β-catenin transcriptional activity that coincides with the disassembly of the complex. Our results establish that β-catenin, but not its transcriptional activity, is central to pluripotency acting through a β- catenin/Oct4 complex.
    [Show full text]
  • Beta;-Catenin Signaling in Rhabdomyosarcoma
    Laboratory Investigation (2013) 93, 1090–1099 & 2013 USCAP, Inc All rights reserved 0023-6837/13 Characterization of Wnt/b-catenin signaling in rhabdomyosarcoma Srinivas R Annavarapu1,8,9, Samantha Cialfi2,9, Carlo Dominici2,3, George K Kokai4, Stefania Uccini5, Simona Ceccarelli6, Heather P McDowell2,3,7 and Timothy R Helliwell1 Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and accounts for about 5% of all malignant paediatric tumours. b-Catenin, a multifunctional nuclear transcription factor in the canonical Wnt signaling pathway, is active in myogenesis and embryonal somite patterning. Dysregulation of Wnt signaling facilitates tumour invasion and metastasis. This study characterizes Wnt/b-catenin signaling and functional activity in paediatric embryonal and alveolar RMS. Immunohistochemical assessment of paraffin-embedded tissues from 44 RMS showed b-catenin expression in 26 cases with cytoplasmic/membranous expression in 9/14 cases of alveolar RMS, and 15/30 cases of embryonal RMS, whereas nuclear expression was only seen in 2 cases of embryonal RMS. The potential functional significance of b-catenin expression was tested in four RMS cell lines, two derived from embryonal (RD and RD18) RMS and two from alveolar (Rh4 and Rh30) RMS. Western blot analysis demonstrated the expression of Wnt-associated proteins including b-catenin, glycogen synthase kinase-3b, disheveled, axin-1, naked, LRP-6 and cadherins in all cell lines. Cell fractionation and immunofluorescence studies of the cell lines (after stimulation by human recombinant Wnt3a) showed reduced phosphorylation of b-catenin, stabilization of the active cytosolic form and nuclear translocation of b-catenin. Reporter gene assay demonstrated a T-cell factor/lymphoid-enhancing factor-mediated transactivation in these cells.
    [Show full text]
  • Demineralized Bone Alters Expression of Wnt Network Components During Chondroinduction of Post-Natal fibroblasts Karen E
    OsteoArthritis and Cartilage (2004) 12, 497–505 © 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.joca.2004.02.009 International Cartilage Repair Society Demineralized bone alters expression of Wnt network components during chondroinduction of post-natal fibroblasts Karen E. Yates Ph.D* Department of Orthopedic Surgery, Brigham and Women’s Hospital, and Skeletal Biology Research Center, Massachusetts General Hospital, Boston, USA Summary Objective: The Wnt family of secreted proteins, their receptors (Fzd proteins) and antagonists (secreted Fzd-related proteins, or Sfrp) regulate chondrocyte differentiation and chrondrogenesis during embryonic development. Here, the hypothesis that the Wnt regulatory network contributes to chondrocyte differentiation of post-natal cells was tested in an in vitro model of chondroinduction by demineralized bone powder (DBP). Design: Human dermal fibroblasts (hDFs) were cultured in porous, three-dimensional (3D) collagen sponges with or without chondroinduc- tive DBP. In some experiments, lithium chloride (LiCl), an agonist of the Wnt/-catenin signaling pathway, was added to the culture media. Sponges were cultured for intervals (0.5–21 days) before processing for molecular, histologic, and biochemical analyses. Expression of wnt, fzd, and sfrp genes was characterized by semi-quantitative RT-PCR. Fibroblasts’ contacts with DBP were documented by histology. Accumulation of proteoglycan in extracellular matrix was evaluated by histology (metachromasia in toluidine blue-stained sections) and quantitative immunoassay (chondroitin 4-sulfate ELISA). Results: Expression of 15 wnt, fzd, and sfrp family members was detected in hDFs by RT-PCR. A subset of those genes (wnt2b, wnt5b, wnt10b, fzd6, fzd7) showed altered expression in hDFs exposed to DBP for 3 days.
    [Show full text]
  • Wnt3a: Functions and Implications in Cancer Sha He1,2, Yi Lu1,2, Xia Liu1,2, Xin Huang1,2, Evan T
    He et al. Chin J Cancer (2015) 34:50 DOI 10.1186/s40880-015-0052-4 REVIEW Open Access Wnt3a: functions and implications in cancer Sha He1,2, Yi Lu1,2, Xia Liu1,2, Xin Huang1,2, Evan T. Keller3, Chao‑Nan Qian4* and Jian Zhang1,2,3* Abstract Wnt3a, one of Wnt family members, plays key roles in regulating pleiotropic cellular functions, including self-renewal, proliferation, differentiation, and motility. Accumulating evidence has suggested that Wnt3a promotes or suppresses tumor progression via the canonical Wnt signaling pathway depending on cancer type. In addition, the roles of Wnt3a signaling can be inhibited by multiple proteins or chemicals. Herein, we summarize the latest findings on Wnt3a as an important therapeutic target in cancer. Keywords: Wnt3a, The Wnt signaling pathway, Cancer Background: the Wnt signaling pathway cell polarity pathway (Wnt-PCP pathway) and the Wnt- The Wnt gene was first identified in 1982 and is named calcium pathway (Wnt-Ca2+ pathway) [5]. According to the Int gene in mice [1]. A subsequent study reported the characteristics of its functions, the Wnt family can that the Int gene and wingless gene in Drosophila were also be divided into two categories: Wnt1 and Wnt5a. homologous genes [2]. Therefore, both genes were rec- The Wnt1 category includes Wnt1, Wnt2, Wnt2b, Wnt3, ognized as the Wnt gene [3]. The Wnt family comprises Wnt3a, Wnt7a, Wnt8, Wnt8b, and Wnt10a, which are 19 human proteins, including Wnt1, Wnt2, Wnt2b involved in the canonical signaling pathway, whereas (Wnt13), Wnt3, Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt4, Wnt5a, and Wnt11 belong to the Wnt5a category Wnt7a, Wnt7b, Wnt8a, Wnt8b, Wnt9a (Wnt14), Wnt9b and activate the noncanonical signaling pathway.
    [Show full text]